Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

InspireMD (NSPR) Shares Issued (2016 - 2025)

InspireMD filings provide 13 years of Shares Issued readings, the most recent being -$21.9 million for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to -$21.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a 144.91% increase, with the full-year FY2025 number at $16.9 million, changed 0.01% from a year prior.
  • Shares Issued hit -$21.9 million in Q4 2025 for InspireMD, down from $36.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $36.8 million in Q3 2025 to a low of -$36.5 million in Q3 2023.
  • Median Shares Issued over the past 4 years was $1000.0 (2021), compared with a mean of $1.6 million.
  • The widest YoY moves for Shares Issued: up 1168833.33% in 2021, down 138.89% in 2021.
  • InspireMD's Shares Issued stood at -$35000.0 in 2021, then crashed by 104282.86% to -$36.5 million in 2023, then surged by 97.26% to -$1.0 million in 2024, then tumbled by 2085.9% to -$21.9 million in 2025.
  • The last three reported values for Shares Issued were -$21.9 million (Q4 2025), $36.8 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.